KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Gains from Investment Securities: 2019-2024

Historic Gains from Investment Securities for Hims & Hers Health (HIMS) over the last 6 years, with Dec 2024 value amounting to $52.5 million.

  • Hims & Hers Health's Gains from Investment Securities rose 541.73% to $69.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.2 million, marking a year-over-year increase of 310.46%. This contributed to the annual value of $52.5 million for FY2024, which is 272.45% up from last year.
  • As of FY2024, Hims & Hers Health's Gains from Investment Securities stood at $52.5 million, which was up 272.45% from $14.1 million recorded in FY2023.
  • In the past 5 years, Hims & Hers Health's Gains from Investment Securities registered a high of $52.5 million during FY2024, and its lowest value of -$59,000 during FY2020.
  • For the 3-year period, Hims & Hers Health's Gains from Investment Securities averaged around $23.5 million, with its median value being $14.1 million (2023).
  • In the last 5 years, Hims & Hers Health's Gains from Investment Securities tumbled by 107.81% in 2020 and then skyrocketed by 10,266.10% in 2021.
  • Over the past 5 years, Hims & Hers Health's Gains from Investment Securities (Yearly) stood at -$59,000 in 2020, then spiked by 10,266.10% to $6.0 million in 2021, then tumbled by 34.96% to $3.9 million in 2022, then soared by 261.34% to $14.1 million in 2023, then surged by 272.45% to $52.5 million in 2024.